Latest News and Press Releases
Want to stay updated on the latest news?
-
Agios provides update on Phase 2b trial of tebapivat in lower-risk myelodysplastic syndromes
Want to stay updated on the latest news?
Agios provides update on Phase 2b trial of tebapivat in lower-risk myelodysplastic syndromes